Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMO | O15229 | 1/20 | 0.41 |
| ▸ | MAPK7 | Q13164 | 7/20 | 0.40 |
| ▸ | PROKR1 | Q8TCW9 | 1/20 | 0.38 |
| ▸ | TRPC6 | Q9Y210 | 4/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | QDPR | P09417 | 1/20 | 0.36 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.36 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14991022 | 0.83 | HTT (0.51) | MEN1KMT2A | |
| SCHEMBL25465007 | 0.80 | CYP2C19 (0.41) | KMOCYP2C19CYP17A1 | |
| SCHEMBL10323271 | 0.80 | KMO (0.45) | KMOMAPK7PROKR1TRPC6CYP17A1 | |
| SCHEMBL17613226 | 0.80 | CYP2C19 (0.41) | KMOMAPK7PROKR1TRPC6CYP2C19 | |
| SCHEMBL21597925 | 0.78 | HTR1A (0.53) | MAPK7MEN1KMT2ALMNA | |
| SCHEMBL25791777 | 0.77 | KMO (0.44) | KMOPROKR1CYP2C19CYP17A1 | |
| SCHEMBL1557826 | 0.76 | GPR119 (0.49) | — | |
| SCHEMBL15191875 | 0.75 | TRPC6 (0.48) | TRPC6 | |
| SCHEMBL14990759 | 0.73 | HTR2C (0.41) | CYP2C19MEN1KMT2A | |
| SCHEMBL22143097 | 0.72 | PIK3CD (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013083741-A1 | 1,2,4 -TRIAZOLES AS ALLOSTERIC MODULATORS OF MGLU5 RECEPTOR ACTIVITY FOR THE TREATMENT OF SCHIZOPHRENIA OF DEMENTIA | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2013-06-13 | — | — | WO | disclosed |